ライフサイエンスコーパス: immunize

1 idth of the ORV zone and proportion of hosts immunized.

2 ups of 15 healthy, malaria-naive adults were immunized.

3 Two thousand immunized (2 doses of measles-mumps-rubella [MMR] vaccin

4 Reactive vaccination immunizing 20% of the livestock population reduced the n

5 f 66 healthy term infants from a 2011 study, immunized according to the same schedule with the same v

6 In Mexico, HPV vaccines available immunize against genotypes 16/18 and 16/18/6/11; however

7 tibody from an Indian dromedary camel (ICab) immunized against a bacterial 14TM helix transporter, No

8 challenging a S. thermophilus strain CRISPR-immunized against a set of virulent phages, we found one

9 , patients with Alzheimer's disease actively immunized against amyloid-beta can remain virtually plaq

10 es of IgG-secreting cells we measure in mice immunized against Tetanus Toxoid under largely varying c

11 f AAVs and Cas9 in mice that were previously immunized against the AAV vector and the Cas9 cargo.

12 HCMV infection, we show that rhesus macaques immunized against viral interleukin-10 (IL-10) manifest

13 10 years after the initial dose with de novo-immunized age-matched controls.

14 Nine cynomolgus macaques were immunized and boosted with the measles virus-vectored ch

15 Lesions in Neu5Gc-immunized and Neu5Gc-rich HFD-fed Cmah (-/-) Ldlr (-/-)

16 Subsequently, the humanized antibody was de-immunized and site-specific mutations were introduced to

17 Immunized and unvaccinated control participants underwen

18 total of 1375 participants were randomized, immunized, and followed for safety and immunogenicity.

19 , in nature, bacteria are frequently not pre-immunized, and phage populations are often not clonal, e

20 ve transfer of sera from VSV-eGFP-SARS-CoV-2-immunized animals also protects naive mice from SARS-CoV

21 pes targeted in polyclonal sera, elicited in immunized animals as well as in an HIV-1-infected elite

22 with L. major-infected sand flies, while non-immunized animals develop large and progressive lesions

23 challenge, unimmunized control and s.c.-s.c.-immunized animals developed Chlamydia-specific intestina

24 However, mucosally SC-Ad-immunized animals had lower viral loads in their gastroi

25 h.SOSIP immunogen induced in the majority of immunized animals higher neutralization titers against b

26 Vaginal secretions of p.o.-immunized animals neutralize Chlamydia in vivo, resultin

27 Libraries generated from immunized animals offer the advantage of in vivo affinit

28 Of interest, while immunized animals showed significantly decreased Th2 cyt

29 lus-immunized animals, whereas slow delivery-immunized animals targeted a more diverse set of epitope

30 n was seen following infectious challenge in immunized animals versus controls.

31 When these Env-immunized animals were challenged rectally with simian-h

32 The immunized animals were fully protected against pathogeni

33 une response detected after vaccination, all immunized animals were protected from disease and death

34 ti-F protein IgG antibody levels in both VLP-immunized animals were similar.

35 on of binding antibodies and, in a subset of immunized animals, in the induction of detectable NAb, s

36 -neutralizing epitopes by conventional bolus-immunized animals, whereas slow delivery-immunized anima

37 he vaginal washes and fecal extracts of p.o.-immunized animals.

38 antigenic variants in naturally infected or immunized animals.IMPORTANCE Avian influenza H7N9 viruse

39 nd were studied by indirect methods, such as immunizing animals with myelin components or feeding the

40 ycoprotein SOSIP trimers are widely used for immunizing animals.

41 ock-in BCR does not functionally engage with immunizing antigen, we found that chronic immunization i

42 nter B cells with low or no affinity for the immunizing antigen.

43 Mice immunized as infants with YopB+dmLT or LcrV+dmLT achieve

44 We demonstrate here that PLP(ECD)-immunized B cell-deficient mice failed to exhibit EAE.

45 CRISPR adaptation immunizes bacteria and archaea against viruses.

46 identify novel biomarkers of senescence, we immunized BALB/c mice with senescent mouse lung fibrobla

47 In a pilot study, we immunized bats with one of four vaccine treatments or ph

48 e BLT model for HIV-1 vaccine development by immunizing BLT mice against the conserved viral Gag prot

49 Tanzanian adult male volunteers were immunized by direct venous inoculation with radiation-at

50 Animals immunized by only the i.m. route had high peripheral T f

51 Animals immunized by only the i.m. route had lower antibody-depe

52 Conversely, animals immunized by the i.n.

53 fic cellular responses in the skin than mice immunized by the intramuscular route.

54 ty (ADCC) antibody activity, whereas animals immunized by the mucosal i.n.

55 B+(GRZ) T cells appeared in more individuals immunized by the t.c.

56 Immunized C3(-/-)C5(-/-) recipients of WT MD4 bone marro

57 CD4(+)CD62L(-)CD44(hi) T cells from gliadin-immunized C57BL/6 mice and were fed with an AIN-76A-base

58 We immunized C57BL/6 mice with these fusion proteins and fo

59 ng-remitting disease phenotype in MOG(35-55)-immunized C57BL/6 mice.

60 ilt from mononuclear cells isolated from the immunized camel and purified the antibody from Escherich

61 ell epitope tt830-843 (CuMV(TT)) was used to immunize cats.

62 Fel d 1-induced allergy in human subjects by immunizing cats against their own major allergen, Fel d

63 PCV13-immunized children aged 13-48 months, N = 988, were enro

64 CV7-immunized children, carriage among PCV13-immunized children was significantly lower for serotypes

65 Compared with PCV7-immunized children, carriage among PCV13-immunized child

66 valent pneumococcal conjugate vaccine (PCV7) immunized children, N = 567, enrolled between November 2

67 examine the results of stopped or failed non-immunizing control measures in endemic settings.

68 ses often forces policymakers to rely on non-immunizing control measures, such as vector control, to

69 on-level loss of immunity resulting from non-immunizing controls and is seen in a variety of models w

70 and is seen in a variety of models when non-immunizing controls are used against an infection that c

71 t stopping control programs that rely on non-immunizing controls, our results strongly argue that the

72 ing experimental and reference antisera from immunized, convalescent, and naive animals (n = 172).

73 ant levels of protection of the offspring of immunized dams from RSV challenge.

74 Importantly, the offspring of UC-3 F VLP-immunized dams showed significant protection from lung p

75 The immunized dams transfer maternal antibodies to pups, whi

76 In addition, offspring of immunized dams were substantially protected from behavio

77 producing CD4(+) but not CD8(+) T cells from immunized donor mice were sufficient for eliminating Chl

78 of a human antibody derived from volunteers immunized during a malaria vaccine trial.

79 dataset on the basis of documented previous immunizing events (transplant, pregnancy, or transfusion

80 Studies aiming to prove this concept by immunizing experimental animals with oxidized LDL partic

81 ephalomyelitis (EAE) and facial allodynia in immunized female mice.

82 An important proportion of subjects immunized for measles do not show a protective IgG titer

83 Here, to test this hypothesis, we immunized four cows with BG505 SOSIP.

84 The fact that immunized gamma interferon (IFN-gamma)-KO mice and wild-

85 -neutralizing human monoclonal antibodies by immunizing genetically engineered mice that have a full

86 largely recognized the HA head region of the immunizing H5N1 strain.

87 Here, we further showed that sera from V160-immunized HCMV-seronegative subjects have attributes sim

88 while striving to find a suitable vaccine to immunize healthy individuals.

89 s differed between control and inhibin alpha-immunized heifers, casting further doubt on thecal inhib

90 We passively immunized huFcepsilonRIalpha mice, as well as human cord

91 We actively immunized huFcepsilonRIalpha/F709 mice, which express hu

92 Analysis of single memory B cells from immunized human donors has led us to characterize a prev

93 rofiles in Yellow Fever vaccine 17D (YF-17D) immunized human subjects.

94 proximately 2 billion tOPV doses per year to immunize hundreds of millions of children.

95 BALB/c mice were immunized i.m. with plasmid DNA encoding a model Ag HIV-

96 ry CD8 T cells from the livers of previously immunized IFN-1 signaling-deficient mice confers greater

97 the eyes dramatically increased in recoverin-immunized IL-10 KO mice.

98 eflect a systemic immune deficiency, because immunized IL-1R1(-/-) mice survived subsequent lethal VA

99 monoclonal antibodies from human volunteers immunized in a clinical vaccine trial of PvDBP.

100 alpis, the sand fly vector of leishmaniasis, immunize individuals with L. longipalpis salivary antige

101 In immunized individuals, 64% were found to have HLA-specif

102 For most immunizing infections, the age distribution of incident

103 lenged with Leishmania major parasites, mice immunized intradermally exhibited significant protection

104 We found that mice immunized intradermally with a synthetic consensus DNA H

105 exhibited significant protection, while mice immunized intramuscularly did not.

106 gen and mucosal adjuvant, respectively, when immunized intranasally in mice.

107 n, alone or combined with LcrV in adult mice immunized intranasally.

108 (-/-) mice were sensitized epicutaneously or immunized intraperitoneally with ovalbumin (OVA) and cha

109 t phage-antibodies against gluten from a non-immunized library of human single-domain antibodies (dAb

110 ncoded HVACC inhibitor by first isolating an immunized llama nanobody (nb.F3) that binds auxiliary HV

111 Analysis of memory B cells from the immunized macaque suggests that elicitation of broadly n

112 Here, we immunized macaques with an HIV envelope trimer, either a

113 ction, decreased viremia was observed in the immunized macaques.

114 We used the two candidate vaccines to immunize mice and later infected them with ZIKV.

115 we further combined DJ NS1 with DENV NS3 to immunize mice and showed activation of Ag-specific CD4(+

116 When we used L. lactis-derived PfCSP4/38 to immunize mice, it elicited high levels of functional ant

117 ns belonging to the three HAstV serotypes to immunize mice.

118 e NAbs than nonattached trimers when used to immunize mice.

119 earlier and stronger protective responses in immunized mice after reinfection with T. cruzi than thos

120 /68 viruses and protection for a majority of immunized mice against a heterologous A/California/07/20

121 totic colon carcinoma CT26 cells efficiently immunized mice against challenge with a breast cancer ce

122 titer of neutralizing antibodies in sera of immunized mice against pseudotyped lentivirus reporter o

123 The immunized mice also developed a robust T cell response.

124 ciated with T cells sharing common TCRs from immunized mice and from patients with food allergy.

125 c CD4(+) T cell proliferation in LdCen(-/-) -immunized mice and impaired protection against virulent

126 polyclonal anti-AAV1 neutralizing sera from immunized mice and rhesus macaques.

127 Topical challenge of immunized mice at a distal site led to significant expan

128 h S Typhimurium, were present in the sera of immunized mice but did not bind live intact Salmonella b

129 ral blood burden was pronouncedly reduced in immunized mice compared to controls.

130 nt for interferon responses in MVA-B13R/SHIV-immunized mice compared to the responses in MVA/SHIV-imm

131 nes were significantly higher in LdCen(-/-) -immunized mice compared with nonimmunized mice that resu

132 ority of HCMVpp65(422-439) and TAF9(134-144) immunized mice developed proteinuria, and their renal pa

133 lls after an established humoral response in immunized mice does not impair protection from a homolog

134 lts show that DCs isolated from protectively immunized mice exhibit enhanced transcriptional activati

135 Neutrophils from ear dLN of LdCen(-/-) -immunized mice exhibited heightened expression of costim

136 However, rAd5-S1- but not rAd5-S1/F/CD40L-immunized mice exhibited marked pulmonary perivascular h

137 e parasitized Nalpha subset from LdCen(-/-) -immunized mice exhibited much stronger Ag-specific CD4(+

138 cific IgG and IgA that were protective, with immunized mice exhibiting more rapid bacterial clearance

139 teraction of LdCen(-/-) with neutrophils, we immunized mice intradermally in the ear pinna with LdCen

140 Leukocidin-immunized mice produce potent leukocidin-neutralizing an

141 Splenic T cells from these immunized mice produced similar levels of IL-2 and IFN-g

142 d PCs after a boost with rLBNSE, rLBNSE-IL-7-immunized mice promptly produced a more potent secondary

143 Results from immunized mice reflected the in vitro observations: T ce

144 uted from the glomeruli of HCMVpp65(422-439) immunized mice showed cross-reactivity with TAF9(134-144

145 At week 4 postimmunization, the OMV-immunized mice showed more robust titers of antibodies a

146 In particular, we show in immunized mice that the carrier protein transthyretin si

147 epertoire diversity: Shannon indices of 4 in immunized mice to 2.6 in persistently infected mice.

148 endoglycosidase Endo H, and intramuscularly immunized mice to examine its efficacy.

149 pearance of the IgG-SCs within the spleen of immunized mice was fast (<24 h) and this early response

150 s played a role in Tfh support of the GC, we immunized mice with a T cell-restricted deletion of the

151 Here, we immunized mice with Ad5 vectors encoding lymphocytic cho

152 We immunized mice with B41 soluble or IO-NP trimers after P

153 We immunized mice with different forms of IgE and tested an

154 tion would enhance this vaccine response, we immunized mice with inactivated vaccine and injected Ag-

155 We also immunized mice with these antigens and assessed the IgG

156 to the challenged animals compared with sham immunized mice, although none of our candidates were as

157 A in bronchoalveolar lavage (BAL) fluid from immunized mice, and Yersinia-specific CD4(+) and CD8(+)

158 well as IL-17, in both lungs and spleens of immunized mice, conferring comprehensive Th1- and Th2-me

159 compromise vaccine efficacy, sera from spike-immunized mice, nonhuman primates, and humans were evalu

160 s in mean intestinal worm and egg burdens in immunized mice, respectively.

161 CspZ FH-binding activity than sera from CspZ-immunized mice.

162 -cell biased immune response observed in Ad4 immunized mice.

163 gG2b-derived Th1 and Th2 responses than LcrV-immunized mice.

164 immune responses were stimulated in the OMV-immunized mice.

165 c CD4(+) T cells from the lung and spleen of immunized mice.

166 d mice compared to the responses in MVA/SHIV-immunized mice.

167 V neutralizing antibody response than rLBNSE-immunized mice.

168 systemic and intestinal humoral responses in immunized mice.

169 We induced autoimmunity to MPO by immunizing mice with MPO in adjuvant; to trigger GN, we

170 rus (RRV) has shown potential as a vector to immunize monkeys with antigens from simian immunodeficie

171 Serum samples collected from 130 immunized monkeys at two key time points were analyzed u

172 ertussis (aP)- than wP-vaccinated infants of immunized mothers, yet quality of antibodies, measured a

173 One way to test a vaccine is to immunize mouse models that express human bnAb precursors

174 )17 immunity, we transplanted irradiated MPO-immunized MPO-deficient mice with bone marrow from eithe

175 nt mice; we also transplanted irradiated MPO-immunized MPO/IL-17A double-deficient mice with bone mar

176 d Daf1(-/-) B2 cells and in hen egg lysozyme-immunized muMT recipients of MD4 B2 cells on each geneti

177 Comparable differences occurred in OVA-immunized muMT recipients of WT, C3ar1(-/-)C5ar1(-/-) ,

178 Monoclonal antibodies from the immunized NHPs were isolated from single plasmablasts an

179 ic for antigen region 3 were produced in the immunized NHPs.

180 We immunized non-lupus-prone mice with 11 allotype "a" of I

181 c CD4(+) effector T cells were isolated from immunized, nontolerant Gucy2c (-/-) mice.

182 the field viruses that likely emerged in the immunized or naturally exposed birds.

183 n ZIKV infection in mice that were passively immunized or preinfected with DENV.

184 B expression, and did not equilibrate among immunized parabiotic mice.

185 ersonalized neoantigen-targeting vaccines to immunize patients newly diagnosed with glioblastoma foll

186 unosuppressed patients and when to optimally immunize patients posttransplant.

187 number of cases of meningococcal disease in immunized patients being treated with eculizumab and sug

188 ion to belatacept in human leukocyte antigen-immunized patients with low DSA levels.

189 i.m.-immunized pigs generated a high titer of neutralizing Ab

190 in spatio-temporally localized sub-optimally immunized populations.

191 ion of tobacco and alcohol, obesity control, immunizing populations against hepatitis B virus infecti

192 addressing the weakest links, which includes immunizing populations in insecure areas and/or with dis

193 gB nucleoside-modified mRNA-LNP-immunized rabbits exhibited an enhanced durability of va

194 Further protective efficacy was observed in immunized rabbits following intramedullary challenge wit

195 o the common glycan hole can be achieved, we immunized rabbits with B41 SOSIP (gp120-gp41 disulfide [

196 We immunized rabbits with the various glycan-modified trime

197 topes targeted on BG505 and B41 SOSIP trimer-immunized rabbits.

198 126 to confer protection against syphilis in immunized rabbits.

199 mpted to mask immunodominant glycan holes by immunizing rabbits with ICs consisting of the BG505 SOSI

200 , whereas uptake in the remote myocardium of immunized rats and controls was low (SUV(mean), 0.4 +/-

201 Results: The myocardium of 10 of 18 immunized rats showed focal macrophage-rich inflammatory

202 Methods: Myocarditis was induced by immunizing rats (n = 18) with porcine cardiac myosin in

203 to belatacept in 29 human leukocyte antigen-immunized renal-transplant recipients.

204 g synthetic resistance, reversal drives, and immunizing reversal drives.

205 Myeloid cells from immunized Stat3 mutant mice exhibited impaired antigen-p

206 1 strains closely matched in sequence to the immunizing strain.

207 The results of immunized studies showed all three glycoconjugates elici

208 re is no formal recommendation about testing immunized subjects (in particular, healthcare workers [H

209 We immunized Syrian hamsters with the best long-term stable

210 When used for immunizing test animals, they elicit antibodies that neu

211 Eight to 12 weeks later, mice were immunized twice with a mixture of adjuvanted HBV S and c

212 e: current heuristic methods are designed to immunize vital nodes or modify a network to a specific o

213 Healthy, adult malaria-naive volunteers were immunized with 3 intramuscular injections of 20 mug (n =

214 hteen IBH-affected horses were recruited and immunized with 300 mug of eIL-31-CuMVTT vaccine or place

215 Thirty Icelandic horses were immunized with 300 mug of eIL-5-CuMV(TT) without adjuvan

216 Mice immunized with 6PGD(391-410), or with S. aureus containi

217 In this study, C57BL/6 mice were immunized with a cocktail of keyhole limpet hemocyanin-c

218 Mice immunized with a combination of human EFs plus rat EFs b

219 virus (RSV) infection of children previously immunized with a nonlive, formalin-inactivated (FI)-RSV

220 and somatic hypermutation in cells from mice immunized with a vaccine target, a multifunctional enzym

221 ty-two rhesus macaques (Macaca mulatta) were immunized with Ad26 vectors that encoded S variants or s

222 CD1c+CD11c+ human DCs isolated from HIS mice immunized with adenoviruses expressing malaria/human imm

223 era from small animals and nonhuman primates immunized with an experimental SARS-CoV-2 vaccine.

224 s) and the memory B cell compartment in mice immunized with an HIV-1 antigen.

225 y analyzing antibodies derived from patients immunized with an sLeA/KLH vaccine.

226 BALB/c mice immunized with BcfA alone or a trivalent vaccine contain

227 Serum from humans immunized with Bexsero was investigated to assess the na

228 Mice immunized with chi10069(pYA5199) also exhibited complete

229 m challenge with leukemia if they were first immunized with CnB-deficient leukemia, suggesting robust

230 In mice immunized with CNS-specific myelin antigens, we observed

231 om cytokines secreted by splenocytes of mice immunized with CpG 1018 and alum.

232 antigen-specific antibody responses in mice immunized with dengue virus envelope domain III protein

233 of individuals naturally exposed to DENV or immunized with DENV (TV005) or YF17D vaccine.

234 ungs of the RSV-challenged offspring of dams immunized with DS-Cav1 F VLPs.

235 n those in the sera of the offspring of dams immunized with DS-Cav1 VLPs.

236 an controls (n = 78) to be age-appropriately immunized with DTaP (41% vs 89%, P < .001) and PCV (59%

237 Syrian hamsters immunized with FiloRab1 PBV-processed vaccines stored at

238 Finally, mice immunized with Flublok and Flucelvax also induced simila

239 nfection of seronegative children previously immunized with formalin-inactivated (FI) RSV has been as

240 When immunized with gp150 complexed to BMS-529, rhesus macaqu

241 VZV-seropositive Kenyan women (n = 44) were immunized with high-dose live attenuated VZV vaccine, an

242 er, for one reconstitution cohort, some mice immunized with iDCpp65 showed GVH-like signs on the skin

243 In mice passively immunized with intravenous Ig, IdeS administration decre

244 Further studies showed that mice immunized with LBNSE-CXCL13 produced more rabies virus-n

245 Mice immunized with LmCen(-/-) have no visible lesions follow

246 We previously showed that humanized mice immunized with long-lived induced-dendritic cells loaded

247 Fc-mediated protective mechanisms in animals immunized with monovalent versus polyvalent vaccines.

248 neutralizing monoclonal antibody in a mouse immunized with mosaic RBD-np.

249 Horses immunized with nanoparticles harboring surface glycoprot

250 Cmah (-/-) Ldlr (-/-) mice immunized with Neu5Gc-bearing antigens to generate human

251 an complement-mediated SBA responses in mice immunized with NOMV with overexpressed FHbp subfamily B

252 Mice immunized with NOMV-FHbp and NOMV-KO vaccines also elici

253 Rhesus macaques (RMs) were immunized with NPs containing TLR4 and TLR7/8 agonists m

254 - and post-immunization sera from 133 adults immunized with one of three types of influenza vaccines

255 However, animals that were immunized with only a RABV expressing the attachment pro

256 VA (nOVAmax) were performed before mice were immunized with or without gastric acid-suppression medic

257 nx significantly dropped in animals formerly immunized with PE-PilA, and in chinchillas, signs of oti

258 ated invariant T cells in healthy volunteers immunized with PfSPZ Vaccine and challenged by CHMI usin

259 n-specific CD4+ T cells was detected in mice immunized with PI-WCV.

260 BALB/c mice were immunized with PM alone or adsorbed to alum.

261 Birds immunized with pQAC-N showed reduced clinical severity a

262 single-domain antibodies (VHHs) from a llama immunized with prefusion-stabilized coronavirus spikes.

263 Furthermore, mice immunized with RBD-NVP induced robust and long-lasting a

264 Mice immunized with recombinant LJM17 produced IgG1 antibodie

265 serum nAb titers from a total of 78 animals immunized with recombinant native-like (SOSIP) Env trime

266 To test this, rhesus macaques were immunized with replicating single-cycle adenovirus (SC-A

267 we show that IFN-1 signaling-deficient mice immunized with replication-competent sporozoites exhibit

268 Passive transfer of sera from mice immunized with rewired virus vaccines shows better prote

269 We isolated three mAbs from mice immunized with selected gp120-CD4i fusion proteins and f

270 Consistently, we found that mice immunized with selected gp120-CD4i fusion proteins have

271 4) Animals immunized with SERCA2a 971-990 showed Ag-specific Abs wi

272 The sera from rabbits immunized with several CONE immunogens display Env bindi

273 Rabbits immunized with SOSIP-NVP elicited strong neutralizing an

274 In this study of pregnant BALB/c mice immunized with subunit H1N1 influenza vaccine, we demons

275 Mice immunized with terminal disaccharide-CRM197 constructs p

276 s were comparable between adults and infants immunized with the alum/MNrgp120 vaccine (gp120 median f

277 Healthcare workers (HCWs) were immunized with the AS03-adjuvanted H1N1pdm09 vaccine in

278 Dams immunized with the extracellular portion of Caspr2 expre

279 and 804 [adults], P = 0.50), whereas infants immunized with the MF59/SF-2 rgp120 vaccine had higher-m

280 ing prechallenge and after challenge of pigs immunized with the naturally attenuated isolate OURT88/3

281 heterologous tier 2 pseudoviruses than those immunized with the noncomplexed ch.SOSIP.

282 Rabbits were immunized with the OMV component or the 3 recombinant an

283 smoke exposure cessation, and the mice were immunized with the P6 lipoprotein from nontypeable Haemo

284 ) and developed better protection than those immunized with the parent virus LBNSE or the GM-CSF-expr

285 Antisera from guinea pigs immunized with the PMD-modified HA show increased cross-

286 6J mice (n = 28) and rhesus macaques (n = 4) immunized with the same HCV E1E2 antigen.

287 We show that mice immunized with these sMVA vectors develop robust SARS-Co

288 Guinea pigs immunized with these two vector vaccines developed high

289 Mice immunized with this antigen and challenged with live Coc

290 Sera from mice immunized with this antigen showed strong inhibition in

291 vaccine compounds, with antibodies from mice immunized with this physical mixture control shown to ef

292 Thirty-nine children were immunized with trivalent LAIV (containing A/H1N1, A/H3N2

293 African green monkeys immunized with two doses of the vector expressing GP fro

294 When B6.DR1/LAIR-1(-/-) mice were immunized with type II collagen they developed more seve

295 ungs of the RSV-challenged offspring of dams immunized with UC-3 F VLPs than in the lungs of the RSV-

296 ers in the sera of the offspring of the dams immunized with UC-3 F VLPs were significantly higher tha

297 Mice immunized with VLP-P47 followed by a boost with Pfs47 mo

298 V-2, mice that expressed human ACE2 and were immunized with VSV-eGFP-SARS-CoV-2 show profoundly reduc

299 Stem immunogenicity is enhanced by immunizing with stem-only constructs or by increasing lo

300 vide synopses of their candidate vaccines to immunize women to protect against congenital CMV disease